Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 44026* | 2013 |
Predictors of hospital mortality in the global registry of acute coronary events CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ... Archives of internal medicine 163 (19), 2345-2353, 2003 | 3153 | 2003 |
Alirocumab and cardiovascular outcomes after acute coronary syndrome GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ... New England Journal of Medicine 379 (22), 2097-2107, 2018 | 3076 | 2018 |
Initial invasive or conservative strategy for stable coronary disease DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ... New England Journal of Medicine 382 (15), 1395-1407, 2020 | 2297 | 2020 |
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) KAA Fox, OH Dabbous, RJ Goldberg, KS Pieper, KA Eagle, F Van de Werf, ... bmj 333 (7578), 1091, 2006 | 2207 | 2006 |
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry KA Eagle, MJ Lim, OH Dabbous, KS Pieper, RJ Goldberg, F Van de Werf, ... Jama 291 (22), 2727-2733, 2004 | 2152 | 2004 |
Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel … SD Wiviott, D Trenk, AL Frelinger, M O’Donoghue, FJ Neumann, ... Circulation 116 (25), 2923-2932, 2007 | 1839* | 2007 |
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease M Cohen, C Demers, EP Gurfinkel, AGG Turpie, GJ Fromell, S Goodman, ... New England Journal of Medicine 337 (7), 447-452, 1997 | 1796 | 1997 |
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1543 | 2018 |
Apixaban with antiplatelet therapy after acute coronary syndrome JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ... New England Journal of Medicine 365 (8), 699-708, 2011 | 1354 | 2011 |
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ... New England Journal of Medicine 380 (16), 1509-1524, 2019 | 1234 | 2019 |
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 KAA Fox, PG Steg, KA Eagle, SG Goodman, FA Anderson, CB Granger, ... Jama 297 (17), 1892-1900, 2007 | 1167 | 2007 |
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1117 | 2012 |
Enoxaparin vs unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary … SYNERGY Trial Investigators Jama 292 (1), 45-54, 2004 | 1086 | 2004 |
Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) KAA Fox, SG Goodman, W Klein, D Brieger, PG Steg, O Dabbous, ... European heart journal 23 (15), 1177-1189, 2002 | 948 | 2002 |
Routine early angioplasty after fibrinolysis for acute myocardial infarction WJ Cantor, D Fitchett, B Borgundvaag, J Ducas, M Heffernan, EA Cohen, ... New England Journal of Medicine 360 (26), 2705-2718, 2009 | 859 | 2009 |
Evacetrapib and cardiovascular outcomes in high-risk vascular disease AM Lincoff, SJ Nicholls, JS Riesmeyer, PJ Barter, HB Brewer, KAA Fox, ... New England Journal of Medicine 376 (20), 1933-1942, 2017 | 804 | 2017 |
Intravenous platelet blockade with cangrelor during PCI DL Bhatt, AM Lincoff, CM Gibson, GW Stone, S McNulty, G Montalescot, ... New England Journal of Medicine 361 (24), 2330-2341, 2009 | 803 | 2009 |
Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events D Brieger, KA Eagle, SG Goodman, PG Steg, A Budaj, K White, ... Chest 126 (2), 461-469, 2004 | 793 | 2004 |
Prehospital ticagrelor in ST-segment elevation myocardial infarction G Montalescot, AW Van't Hof, F Lapostolle, J Silvain, JF Lassen, ... New England Journal of Medicine 371 (11), 1016-1027, 2014 | 786 | 2014 |